apaflurane has been researched along with salmeterol xinafoate in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 10 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ashurst, IC; Chowdhry, BZ; Davies-Cutting, CJ; Michael, Y; Riley, T; Snowden, MJ | 1 |
Currie, GP; Fowler, SJ; Lipworth, BJ | 1 |
Baitinger, L; Dorinsky, P; Greos, LS; Gross, G; Nelson, HS; Scott, C; Wolfe, JD | 1 |
Chopra, N; Jenkins, M; Kahl, L; Rimmer, M; Williams, M | 1 |
Daley-Yates, P; De Silva, M; Handel, M; Kempsford, R; Mehta, R | 1 |
Benissan, LB; Britto, IL; Peyron, ID; Tardieu, BZ | 1 |
Dorinsky, P; Ellsworth, A; House, K; Nathan, RA; Rooklin, A; Schoaf, L; Scott, C | 1 |
Carranza-Rosenzweig, J; Crim, C; Lincourt, WR; Locantore, NW; Sheth, K; Wasserman, RL | 1 |
Marriott, C; Martin, GP; Murnane, D | 1 |
Andersen, LB; Edin, HM; Ho, SY; Ortega, HG; Schoaf, L; Scott-Wilson, CA | 1 |
7 trial(s) available for apaflurane and salmeterol xinafoate
Article | Year |
---|---|
Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosol Propellants; Aged; Albuterol; Androstadienes; Anti-Inflammatory Agents; Asthma; Beclomethasone; Bronchial Provocation Tests; Bronchodilator Agents; Drug Administration Schedule; Drug Therapy, Combination; Fluticasone; Humans; Hydrocarbons, Fluorinated; Middle Aged; Outcome Assessment, Health Care; Quality of Life; Respiratory Function Tests; Salmeterol Xinafoate | 2002 |
Efficacy and safety of fluticasone propionate 44 microg/salmeterol 21 microg administered in a hydrofluoroalkane metered-dose inhaler as an initial asthma maintenance treatment.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Albuterol; Androstadienes; Asthma; Bronchodilator Agents; Child; Drug Therapy, Combination; Female; Fluticasone; Humans; Hydrocarbons, Fluorinated; Male; Metered Dose Inhalers; Middle Aged; Salmeterol Xinafoate; Time Factors; Treatment Outcome | 2003 |
Salmeterol HFA is as effective as salmeterol CFC in children and adults with persistent asthma.
Topics: Adolescent; Adult; Aerosol Propellants; Aged; Albuterol; Anti-Asthmatic Agents; Asthma; Chemical Phenomena; Chemistry, Physical; Child; Child, Preschool; Chlorofluorocarbons; Circadian Rhythm; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Hydrocarbons, Fluorinated; Male; Metered Dose Inhalers; Middle Aged; Peak Expiratory Flow Rate; Salmeterol Xinafoate; Treatment Outcome | 2005 |
Comparison of the systemic pharmacodynamic effects and pharmacokinetics of salmeterol delivered by CFC propellant and non-CFC propellant metered dose inhalers in healthy subjects.
Topics: Adolescent; Adult; Aerosol Propellants; Albuterol; Anti-Asthmatic Agents; Asthma; Chemical Phenomena; Chemistry, Physical; Chlorofluorocarbons; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Heart Rate; Humans; Hydrocarbons, Fluorinated; Male; Metered Dose Inhalers; Middle Aged; Potassium; Salmeterol Xinafoate | 2005 |
Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Topics: Adolescent; Adult; Aerosol Propellants; Aged; Aged, 80 and over; Albuterol; Androstadienes; Asthma; Bronchodilator Agents; Child; Double-Blind Method; Drug Administration Schedule; Female; Fluticasone; Follow-Up Studies; Forced Expiratory Volume; Humans; Hydrocarbons, Fluorinated; Male; Metered Dose Inhalers; Middle Aged; Salmeterol Xinafoate; Spirometry; Time Factors; Treatment Outcome | 2006 |
Fluticasone propionate/salmeterol hydrofluoroalkane via metered-dose inhaler with integrated dose counter: Performance and patient satisfaction.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Female; Fluticasone; Humans; Hydrocarbons, Fluorinated; Male; Metered Dose Inhalers; Middle Aged; Patient Satisfaction; Powders; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate; Treatment Outcome | 2006 |
Effects of fluticasone propionate and salmeterol hydrofluoroalkane inhalation aerosol on asthma-related quality of life.
Topics: Administration, Inhalation; Adult; Aerosol Propellants; Albuterol; Androstadienes; Asthma; Bronchodilator Agents; Double-Blind Method; Drug Combinations; Female; Fluticasone; Fluticasone-Salmeterol Drug Combination; Humans; Hydrocarbons, Fluorinated; Male; Metered Dose Inhalers; Quality of Life; Salmeterol Xinafoate; Surveys and Questionnaires; Treatment Outcome; United States | 2009 |
3 other study(ies) available for apaflurane and salmeterol xinafoate
Article | Year |
---|---|
Characterisation of the aggregation behaviour in a salmeterol and fluticasone propionate inhalation aerosol system.
Topics: Administration, Inhalation; Aerosols; Albuterol; Androstadienes; Anti-Asthmatic Agents; Chemistry, Pharmaceutical; Chlorofluorocarbons, Ethane; Chlorofluorocarbons, Methane; Drug Interactions; Fluticasone; Hydrocarbons, Fluorinated; Salmeterol Xinafoate | 2001 |
Development and performance of a new hydrofluoroalkane (HFA 134a)-based metered dose inhaler (MDI) of salmeterol.
Topics: Administration, Inhalation; Aerosol Propellants; Albuterol; Anti-Asthmatic Agents; Chemical Phenomena; Chemistry, Physical; Chlorofluorocarbons; Drug Administration Schedule; Equipment Design; Humans; Hydrocarbons, Fluorinated; Materials Testing; Metered Dose Inhalers; Particle Size; Reproducibility of Results; Salmeterol Xinafoate | 2005 |
Investigations into the formulation of metered dose inhalers of salmeterol xinafoate and fluticasone propionate microcrystals.
Topics: Administration, Inhalation; Aerosol Propellants; Aerosols; Albuterol; Androstadienes; Bronchodilator Agents; Chemistry, Pharmaceutical; Crystallization; Drug Stability; Fluticasone; Hydrocarbons, Fluorinated; Metered Dose Inhalers; Particle Size; Polyethylene Glycols; Pressure; Reproducibility of Results; Salmeterol Xinafoate; Technology, Pharmaceutical | 2008 |